Cholecalciferol
In clinical developmentAlso known as (+)-vitamin D3, Activated 7-dehydrocholesterol, Animi-3 with Vitamin D, CC+70 more
(+)-vitamin D3, Activated 7-dehydrocholesterol, Animi-3 with Vitamin D, CC, Cal-Quick, Calafol Rx, Calcarb with D, Calcet, Calciol, Caltrate 600 with Iron and Vitamin D, Caltrate Gummy Bites, Caltrate Plus D, Colecalciferol, Colecalciferolum, D-Vi-Sol, D3, D3 + K2, D3 - cholecalciferol, D3 - colecalciferol, D3 Dots, Decalcitrol, Decara, Delta D3, Dialyvite Vitamin D3 Max, Encora AM Tablet, Encora PM Tablet, Folditam, Folgard OS, Folixate, Fosamax Plus D, Infuvite, Infuvite Pediatric, Lactocal, MVC-Fluoride, Maximum D3, Multi-Delyn, Natafort, Nephrocaps QT, Oleovitamin D3, Os-Cal 500 + D, Os-Cal 500 with D, Osteo-Poretical, Ostercal-D, Oysco 500 with D, Oysco D, Poly-Vi-Sol, Poly-Vi-Sol with Iron, PreNexa, ReliOn Glucose, Replesta NX, Thera-D, Tri-Vi-Sol, Tri-Vi-Sol with Iron, VITD - Colecalciferol, VITD - cholecalciferol, Vitafol-One, Vital E- A + D3, Vital E- Newborn, Vital E- Repro, Vitamin D (Cholecalciferol), Vitamin D 3, Vitamin D-3, Vitamin D3, Vitamin D>3<, Vitamin-D3, cholecalciferol (vitamin D3), (5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-trien-3-ol, Calcium Carbonate with Vitamin D3, Calcium Citrate with Vitamin D3, Calcium Citrate+D3, Calvite P/D, Cholecalciferolum, Oysco D with Calcium, Viactiv Calcium Plus D.
Recent clinical, regulatory, research and industry developments relating to this drug.
Effect of Vitamin D and Omega-3 Fatty Acids on Blood Pressure and Hypertension
Vitamin D<sub>3</sub> Receptors and Metabolic Enzymes in Hen Reproductive Tissues.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Pharmacology & targets
Known molecular targets and mechanisms supported by curated pharmacology databases.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Effect of Vitamin D Injection on Hypertrophic Scars and Keloids
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- International journal of molecular sciences2
- Andrology1
- Clinical journal of the American Society of Nephrology : CJASN1
- Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists1
- Journal of the American Society of Nephrology : JASN1
- Amodeo S1
- Argano C1
- Binongo JN1
- Blomberg Jensen M1
- Chandra P1
- Corrao S1
- Grzesiak M1
- Holt R1
- Copenhagen University Hospital - Herlev and Gentofte1
- Copenhagen University Hospital - Rigshospitalet1
- Department of Clinical Medicine1
- Doctoral School of Exact and Natural Sciences1
- Emory University1
- Indiana University School of Medicine1
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Acts on the same molecular target as Cholecalciferol, with 9 overlapping disease areas.
Studied across 8 of the same disease areas as Cholecalciferol in the shared literature.
Studied across 7 of the same disease areas as Cholecalciferol in the shared literature.
Studied across 5 of the same disease areas as Cholecalciferol in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials